Diagnostic yield of clinical exome sequencing in 868 children with neurodevelopmental disorders.
AuteursNeuens S, Soblet J, Penninckx A, Detry C, Badoer C, Desmyter L, Peyrassol X, Wilkin F, Busson A, Bruneau M, Grenet ML, Le Morillon A, Aeby A, Deconinck N, Prigogine C, Monier A, Juvené E, Balfroid T, Van Hecke A, Christiaens F, Depondt C, Brachet C, Delvenne V, Lufin N, Bouysran Y, Kammoun M, Daneels D, Caljon B, Croes D, Olsen C, Van Dooren S, Migeotte I, Vandernoot I, Marangoni M, Coppens S, Smits G, Vilain C
External multicenter validation of the FAMISH score for predicting metachronous gastric lesions after endoscopic submucosal dissection.
AuteursGarrido M, Almeida TC, Kuttner-Magalhães R, Marcos-Pinto R, Archer S, Pinho R, Estevinho MM, Santos-Antunes J, Morais R, Barreiro P, Simão I, Bourke M, Wang H, Amaro P, Gravito-Soares E, Kuvaev R, Kashin S, Areia M, Viegas MI, Koch AD, Spaander MCW, Provoost N, Manfredi G, Esposito G, Losurdo G, Lemmers A, Fernández-Esparrach G, Santiago ER, Dinis-Ribeiro M, Libânio D
Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial.
AuteursCollet L, Noël JC, Catteau X, Ardin M, Berthet J, Ghamry-Barrin S, Treilleux I, Bengrine Lefevre L, Martinez M, Rothé F, Sotiriou C, Caux C, Dubois B, Ray-Coquard I, Le Saux O
